HYDROXYZINE PAMOATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for hydroxyzine pamoate and what is the scope of freedom to operate?

Hydroxyzine pamoate is the generic ingredient in three branded drugs marketed by Teva, Barr, Beximco Pharms Usa, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, Watson Labs, and Pfizer, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for hydroxyzine pamoate. Thirty suppliers are listed for this compound.

Summary for HYDROXYZINE PAMOATE

US Patents:	0
Tradenames:	3
Applicants:	13
NDAs:	37
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	30
Raw Ingredient (Bulk) Api Vendors:	60
Clinical Trials:	1
Patent Applications:	1,480
Drug Prices:	Drug price trends for HYDROXYZINE PAMOATE
Drug Sales Revenues:	Drug sales revenues for HYDROXYZINE PAMOATE
What excipients (inactive ingredients) are in HYDROXYZINE PAMOATE?	HYDROXYZINE PAMOATE excipients list
DailyMed Link:	HYDROXYZINE PAMOATE at DailyMed

See drug prices for HYDROXYZINE PAMOATE

Drug Sales Revenue Trends for HYDROXYZINE PAMOATE

See drug sales revenues for HYDROXYZINE PAMOATE

Recent Clinical Trials for HYDROXYZINE PAMOATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Shalvata Mental Health Center	N/A

See all HYDROXYZINE PAMOATE clinical trials

Pharmacology for HYDROXYZINE PAMOATE

Drug Class	Antihistamine
Mechanism of Action	Histamine Receptor Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for HYDROXYZINE PAMOATE

N05BB	Diphenylmethane derivatives
N05B	ANXIOLYTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for HYDROXYZINE PAMOATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Heritage Pharma	HYDROXYZINE PAMOATE	hydroxyzine pamoate	CAPSULE;ORAL	201507-002	Jun 3, 2013	AB	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Heritage Pharma	HYDROXYZINE PAMOATE	hydroxyzine pamoate	CAPSULE;ORAL	201507-001	Jun 3, 2013	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Duramed Pharms Barr	HYDROXYZINE PAMOATE	hydroxyzine pamoate	CAPSULE;ORAL	088593-001	Feb 29, 1984		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.